Search research articles
Contact Us
Filters
Showing results (261-270 of 283) with videos related to
Page
of 29
Sort By:
Annals of Hematology
|
October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience
Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
Viruses
|
September 28, 2021
Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
Thomas P Thomopoulos, Margherita Rosati, Evangelos Terpos, et al.
Nature Communications
|
June 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes
Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, et al.
American Journal of Hematology
|
June 3, 2025
Characteristics and Survival Outcomes of Solitary Plasmacytomas: A 30-Year Experience of the Greek Myeloma Study Group on 175 Patients
Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
Microorganisms
|
April 30, 2021
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis
Vasiliki Pappa, Anthi Bouchla, Evangelos Terpos, et al.
Blood Advances
|
January 7, 2026
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Shirley D'Sa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2025
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study
Sikander Ailawadhi, Ivan Špička, Andrew Spencer, et al.
Msphere
|
June 30, 2021
Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020
Evangelia Georgia Kostaki, Georgios A Pavlopoulos, Kleio-Maria Verrou, et al.
The New England Journal of Medicine
|
June 4, 2024
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Thierry Facon, Meletios-Athanasios Dimopoulos, Xavier P Leleu, et al.
Vaccines
|
April 3, 2021
SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
Ourania E Tsitsilonis, Dimitrios Paraskevis, Evi Lianidou, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 283) with videos related to
Sort By:
Page
of 29
Annals of Hematology
|
October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience
Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
Viruses
|
September 28, 2021
Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
Thomas P Thomopoulos, Margherita Rosati, Evangelos Terpos, et al.
Nature Communications
|
June 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes
Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, et al.
American Journal of Hematology
|
June 3, 2025
Characteristics and Survival Outcomes of Solitary Plasmacytomas: A 30-Year Experience of the Greek Myeloma Study Group on 175 Patients
Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
Microorganisms
|
April 30, 2021
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis
Vasiliki Pappa, Anthi Bouchla, Evangelos Terpos, et al.
Blood Advances
|
January 7, 2026
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Shirley D'Sa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2025
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study
Sikander Ailawadhi, Ivan Špička, Andrew Spencer, et al.
Msphere
|
June 30, 2021
Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020
Evangelia Georgia Kostaki, Georgios A Pavlopoulos, Kleio-Maria Verrou, et al.
The New England Journal of Medicine
|
June 4, 2024
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Thierry Facon, Meletios-Athanasios Dimopoulos, Xavier P Leleu, et al.
Vaccines
|
April 3, 2021
SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
Ourania E Tsitsilonis, Dimitrios Paraskevis, Evi Lianidou, et al.
Page
of 29